Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
John GillDirector | AltimmuneALT | Open-market buy | 04/06 | 04/06 | 9,200 sh | $3.41 | $31,372 | +73.6% |
AltimmuneALT | Open-market buy | 04/01 | 04/01 | 10,000 sh | $3.15 | $31,500 | +35.6% | |
Jerome Benedict DursoPresident and CEO | AltimmuneALT | Open-market buy | 04/01 | 04/01 | 15,000 sh | $3.14 | $47,100 | +46.2% |
AltimmuneALT | Open-market buy | 03/06 | 03/09 | 5,000 sh | $3.54 | $17,700 | +21.7% | |
Jerome Benedict DursoPresident and CEO | AltimmuneALT | Open-market buy | 03/06 | 03/09 | 20,000 sh | $3.54 | $70,800 | +160.0% |
Wayne PisanoDirector | AltimmuneALT | Open-market buy | 01/08 | 01/09 | 5,000 sh | $4.08 | $20,400 | +58.8% |
Catherine A. SohnDirector | AltimmuneALT | Open-market buy | 01/05 | 01/05 | 500 sh | $4.24 | $2,120 | +50.0% |
Diane JorkaskyDirector | AltimmuneALT | Open-market buy | 25/12/29 | 25/12/29 | 527 sh | $3.80 | $2,002.6 | No record |
John GillDirector | AltimmuneALT | Open-market buy | 25/12/23 | 25/12/23 | 12,500 sh | $4.10 | $51,250 | No record |
Jerome Benedict DursoDirector | AltimmuneALT | Open-market buy | 25/12/22 | 25/12/22 | 12,500 sh | $4.13 | $51,625 | No record |
Catherine A. SohnDirector | AltimmuneALT | Open-market buy | 25/03/17 | 25/03/18 | 1,000 sh | $5.78 | $5,780 | No record |
AltimmuneALT | Open-market buy | 25/03/13 | 25/03/14 | 10,000 sh | $5.20 | $52,000 | No record | |
AltimmuneALT | Open-market sale | 24/08/19 | 24/08/20 | 16,011 sh2 trades | $6.90avg. | $110,547.03 | −22.4% | |
David DrutzDirector | AltimmuneALT | Open-market buy | 23/08/15 | 23/08/15 | 300 sh | $2.88 | $864 | +1.0% |
John GillDirector | AltimmuneALT | Open-market sale | 22/08/12 | 23/07/06 | 2,714 sh | $15.00 | $40,710 | −49.5% |
David DrutzDirector | AltimmuneALT | Open-market buy | 23/03/23 | 23/03/27 | 9,000 sh | $4.27 | $38,430 | +43.9% |
AltimmuneALT | Open-market buy | 23/03/24 | 23/03/24 | 10,000 sh | $4.31 | $43,100 | +83.3% | |
Matthew Scott HarrisChief Medical Officer | AltimmuneALT | Open-market buy | 23/03/23 | 23/03/23 | 10,000 sh | $4.22 | $42,200 | +42.9% |